The drug firm had reported a profit after tax (PAT) of Rs 210 crore in the October-December period of last fiscal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback